Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemotherapy and Chemoradiotherapy in Non-Metastatic Esophageal Cancer
NCT00735345Phase 2Terminated
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Start
- Aug 2008
- Primary completion
- Dec 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in esophageal cancer, sponsored by Arbeitsgemeinschaft medikamentoese Tumortherapie. Started Aug 2008; status: terminated.
02
Drugs
cetuximab
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00735345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735345.